Under fravær af metaboliske hæmmere udgør renal clearance mindre end 25% af maravirocs total - clearance, hvorfor nedsat nyrefunktion ikke forventes at påvirke eksponering for maraviroc signifikant.
In the absence of metabolic inhibitors, renal clearance accounts for less than 25% of total clearance of maraviroc and hence renal impairment is not expected to significantly alter maraviroc exposures.